	A Systematic Review of Artificial Intelligence-Based Clinical Decision Support Systems in Prostate Cancer Management. Healthc Technol Lett Naderian S, Soleimanzadeh F, Nikniaz L, Sanaie S, Sadeghi-Ghyassi F, Samad-Soltani T. PMID: 41262209 [PubMed]
	Idiopathic isolated adrenocorticotropic hormone deficiency combined with testicular germ cell tumor: Case report. Medicine (Baltimore) Yang M, Lin S, Fu D, Wang Y, Lu S, Li M, Wang X. PMID: 41261694 [PubMed - indexed for MEDLINE]
	Does incidental prostate cancer after holmium laser enucleation of the prostate cause serious clinical problems?: Retrospective study. Medicine (Baltimore) Efendio, Özcan C, Tokatli Z. PMID: 41261687 [PubMed - indexed for MEDLINE]
	Adherence to the 2018 World Cancer Research Fund/American Institute for Cancer Research Cancer Prevention Recommendations and risk of lifestyle-related cancers in the prostate, lung, colorectal, and ovarian cancer screening trial. BJC Rep Malcomson FC, Shams-White MM, Reedy J, Huang WY, Moore SC, Loftfield E. PMID: 41261199 [PubMed]
	Bladder Preservation After Neoadjuvant Therapy for Muscle-invasive Bladder Cancer in the Current Era: Myth and Reality. Eur Urol Focus Crupi E, Necchi A, Kamat AM. PMID: 41261008 [PubMed - as supplied by publisher]
	Clinical outcomes of retreatment or discontinuation after interruption of nivolumab plus ipilimumab due to immune-related adverse events in metastatic renal cell carcinoma patients: A retrospective multicenter study. Urol Oncol Sano Y, Inoue M, Washino S, Shirotake S, Takeshita H, Miura Y, Nakayama A, Nagamoto S, Miyagawa T, Oyama M, Kawakami S, Saito K, Matsuoka Y. PMID: 41260972 [PubMed - as supplied by publisher]
	Circulating Tumor DNA in Muscle-invasive Bladder Cancer: Promise, Pitfalls, and Path Forward. Eur Urol Oncol Cerrato C, Rouprêt M, Mir MC. PMID: 41260941 [PubMed - as supplied by publisher]
	Corrigendum to "Talazoparib plus enzalutamide in metastatic castration-resistant prostate cancer: Safety analyses from the randomized, placebo-controlled, phase III TALAPRO-2 study" [Eur J Cancer 213 (December) (2024) 115078]. Eur J Cancer Azad AA, Fizazi K, Matsubara N, Saad F, De Giorgi U, Joung JY, Fong PCC, Jones RJ, Zschäbitz S, Oldenburg J, Shore ND, Dunshee C, Carles J, Fay AP, Lin X, DeAnnuntis L, Di Santo N, Zielinski MA, Agarwal N. PMID: 41259940 [PubMed - as supplied by publisher]
	Performance of Retrieval-Augmented Generation Large Language Models in Guideline-Concordant Prostate-Specific Antigen Testing: Comparative Study With Junior Clinicians. J Med Internet Res Tung JYM, Le Q, Yao J, Huang Y, Lim DYZ, Sng GGR, Lau RSE, Tan YG, Chen K, Tay KJ, Tan JH, Yuen JSP, Cheng CWS, Ho HSS. PMID: 41259800 [PubMed - indexed for MEDLINE]
	Using ChatGPT-4 for Lay Summarization in Prostate Cancer Research to Advance Patient-Centered Communication: Large-Scale Generative AI Performance Evaluation. J Med Internet Res Rinderknecht E, Engelmann SU, Saberi V, Kirschner C, Kravchuk AP, Schmelzer A, Breyer J, Goßler C, Mayr R, Gilfrich C, Burger M, von Winning D, Borgmann H, Wülfing C, Merseburger AS, Haas M, May M. PMID: 41259712 [PubMed - indexed for MEDLINE]
	Integrated, Cross-Entity Information on Preventive Measures for Bowel, Breast, and Prostate Cancer: Evaluation Study of the Web Application "Prevent-Take-Up". JMIR Cancer Kestler AMR, Schwab JD, Jähnig T, Melzer MK, Zengerling F, Lukac S, Janni W, Bolenz C, Barzel A, Kestler HA, Seufferlein T. PMID: 41259673 [PubMed - indexed for MEDLINE]
	Preoperative role of systemic immune indices in the differential diagnosis between chromophobe renal cell carcinoma and oncocytoma. Urol Int Akta, Be, Sevinç AH, Bozkurt M, Ate, Kad. PMID: 41259276 [PubMed - as supplied by publisher]
	Racial Differences in Adverse Events After Androgen Deprivation in Veterans With Prostate Cancer. JAMA Netw Open Friedrich NA, Janes JL, Parrish J, De Hoedt AM, Josan K, Tatonetti NP, Freedland SJ. PMID: 41259022 [PubMed - indexed for MEDLINE]
	Penile cancer and lymph node management: a call for standardization. Int Urol Nephrol Aveta A, Iossa V, Spena G, Contieri R, Izzo A, Passaro F, Tufano A, Imperatore V, Perdonà S, Romano L, Giulioni C, Cafarelli A, Russo P, Crocerossa F, Lasorsa F, Lucarelli G, Ferro M, Balsamo R, Manfredi C, Arcaniolo D, Siracusano S, Pandolfo SD. PMID: 41258991 [PubMed - as supplied by publisher]
	Expression and diagnostic potential of circulating miR-107, miR-134-5p, miR-149-5p, miR-370-3p, and miR-221 in prostate cancer and benign prostatic hyperplasia: a preliminary study. Arch Ital Urol Androl Akkoç A, Eciroglu Sarban H, Yildiz F, Gunizi OC, Ucar M. PMID: 41258785 [PubMed - as supplied by publisher]
	What do the current popular artificial intelligence chatbots offer us regarding patient information? Comparison of responses from the ten most popular chatbots about bladder cancer. J Cancer Surviv Sahin MF, Akgül M, Akp, Bolat D, Bozkurt O, , Karakoyunlu N, Süer E, T, Turkish Urooncology Association, Bladder Cancer Working Group. PMID: 41258614 [PubMed - as supplied by publisher]
	Prediction of bone or lung metastasis in prostate cancer using machine learning: a SEER-based study with external validation. Discov Oncol Zhong M, Chen R. PMID: 41258601 [PubMed - as supplied by publisher]
	Targeting prostate adenocarcinoma tumor microenvironment via cancer nanotheranostics: a comprehensive update on improved roadmap for disease diagnosis, therapy and management. Clin Transl Oncol Wasai A, Roy A, Pandita D. PMID: 41258335 [PubMed - as supplied by publisher]
	Dietary patterns, polygenic risk, and kidney cancer incidence: a UK Biobank cohort study. J Transl Med Zou M, Deng R, Qiu J, Mao K, Shang J, Zhu S, Cai L, Wang Y, Gong K, Zhou J. PMID: 41257832 [PubMed - indexed for MEDLINE]
	Investigation on the current status of secondary transurethral resection for bladder cancer among Chinese urologists and construction of an acceptance prediction model. BMC Urol Liu X, Sun S, Wang H, Yang S. PMID: 41257657 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 287651

Page 1 of 14383



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy